Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma
- DOI
- 10.1186/s40364-026-00992-2
- Published
- 2026-09-05
- Container
- Biomarker Research
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s40364-026-00992-2,
title = {Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma},
author = {Wenwen Cheng and Silvia Gaggero and Lama Hasan Bou Issa and Aïcha Ouelkdite and Guillaume Escure and Adeline Cozzani and Yanick Njosse Tchantchou and Noémie Carlier and Emilie Wauquier and Gauthier Decool and Rémi Tilmont and Benjamin Podvin and Malo Leprohon and Mojtaba Shekarkar and Léa Fléchon and Angélina Kasprowicz and Sophie Groux-Degroote and Jérôme Moreaux and Bertrand Arnulf and Jill Corre and Céline Villenet and Ludovic Martinet and Xavier Leleu and Martin Figeac and Thierry Facon and Wenfei Jin and Suman Mitra and Salomon Manier},
year = {2026},
journal = {Biomarker Research},
doi = {10.1186/s40364-026-00992-2},
url = {https://doi.org/10.1186/s40364-026-00992-2}
}RIS
TY - JOUR TI - Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma AU - Wenwen Cheng AU - Silvia Gaggero AU - Lama Hasan Bou Issa AU - Aïcha Ouelkdite AU - Guillaume Escure AU - Adeline Cozzani AU - Yanick Njosse Tchantchou AU - Noémie Carlier AU - Emilie Wauquier AU - Gauthier Decool AU - Rémi Tilmont AU - Benjamin Podvin AU - Malo Leprohon AU - Mojtaba Shekarkar AU - Léa Fléchon AU - Angélina Kasprowicz AU - Sophie Groux-Degroote AU - Jérôme Moreaux AU - Bertrand Arnulf AU - Jill Corre AU - Céline Villenet AU - Ludovic Martinet AU - Xavier Leleu AU - Martin Figeac AU - Thierry Facon AU - Wenfei Jin AU - Suman Mitra AU - Salomon Manier PY - 2026 JO - Biomarker Research DO - 10.1186/s40364-026-00992-2 UR - https://doi.org/10.1186/s40364-026-00992-2 ER -
APA
Cheng, W., Gaggero, S., Issa, L. H. B., Ouelkdite, A., Escure, G., Cozzani, A., Tchantchou, Y. N., Carlier, N., Wauquier, E., Decool, G., Tilmont, R., Podvin, B., Leprohon, M., Shekarkar, M., Fléchon, L., Kasprowicz, A., Groux-Degroote, S., Moreaux, J., Arnulf, B., Corre, J., Villenet, C., Martinet, L., Leleu, X., Figeac, M., Facon, T., Jin, W., Mitra, S., & Manier, S. (2026). Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma. Biomarker Research. https://doi.org/10.1186/s40364-026-00992-2
Source records
- crossref · retrieved 2026-09-25T20:02:46.418Z